Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Correction: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Home
Publications
Correction: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Correction: Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Authors:
DH
Doris K. Hansen
Doris K. Hansen
DD
Danai Dima
Danai Dima
HM
Hira Mian
Hira Mian
JD
Jakob Devos
Jakob Devos
RB
Ruta Brazauskas
Ruta Brazauskas
TO
Temitope Oloyede
Temitope Oloyede
AA
Aimaz Afrough
Aimaz Afrough
NA
Nausheen Ahmed
Nausheen Ahmed
LA
Larry D. Anderson
Larry D. Anderson
RB
Rahul Banerjee
Rahul Banerjee
JB
Jesus G. Berdeja
Jesus G. Berdeja
AB
Aram Bidikian
Aram Bidikian
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
31 August 2026
journal article
correction
Published by
Springer Nature
in
Blood Cancer Journal
Vol. 16
(1)
,
145
DOI:
10.1038/s41408-026-01605-9
Abstract
No abstract available
Keywords
CANCER IMMUNOTHERAPY
CANCER THERAPY
BIOMEDICINE
GENERAL
CANCER RESEARCH
ONCOLOGY
HEMATOLOGY
Cited
Cited by 1 article
Scroll to top